NI Medical is a leading brand in the cardiovascular field, offering non-invasive solutions to various challenges in heart health. With a focus on Hypertension, Chronic heart failure, Hemodialysis, ICU/ICCU, Neonatal, Obstetrics & Gynecology, and the treatment of infectious diseases, NI Medical provides innovative products and services for both inpatient and outpatient settings. Their flagship product, the NICaS System, is a state-of-the-art technology that revolutionizes hemodynamic and fluid management.

It offers a much-needed solution, utilizing non-invasive techniques. The system has been extensively researched and validated, showing great correlation with gold standard techniques. NI Medical has a rich history of innovation, with milestones dating back to 1973 when the possibility of bio-impedance for stroke volume calculation was discovered.

Since then, the brand has evolved, developing prototypes, obtaining patents, and establishing itself as a leader in the field. The brand boasts a team of experienced professionals, including Executive Chairman & CFO Eyal Hahn, COO Igor Granov, and Medical Director Prof. Zvi Vered.

With their expertise and the support of an esteemed Advisory Board, NI Medical continues to drive advancements in cardiovascular care